rawfin.tv
Lisata Therapeutics Acquires Marea Therapeutics, Secures $225 Million Financing
MarketsstocksAI Generated

Lisata Therapeutics Acquires Marea Therapeutics, Secures $225 Million Financing

By rawfin.tv Markets Desk||1 min read|AI-assisted · Methodology

Lisata Therapeutics has completed the acquisition of Marea Therapeutics, expanding its clinical-stage drug pipeline. The company also secured $225 million in financing to support its development efforts.

LSTAM&ABiotechnologyPharmaceuticalsSandoz

Related Articles

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

Ambarella Gains as Nvidia Emerges as Potential Third Bidder

stocks
SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

SpaceX and Tesla Boards Review Potential $3.5 Trillion Merger

stocks
Elon Musk Explores Merger Between SpaceX and Tesla

Elon Musk Explores Merger Between SpaceX and Tesla

stocks
Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks